4/6
08:34 am
lpcn
Lipocine (LPCN) had its "neutral" rating reaffirmed by HC Wainwright.
High
Report
Lipocine (LPCN) had its "neutral" rating reaffirmed by HC Wainwright.
4/6
07:56 am
lpcn
Lipocine Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
High
Report
Lipocine Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
3/22
01:04 am
lpcn
Low
Report
3/10
08:00 am
lpcn
Lipocine Announces Financial Results for the Full Year Ended December 31, 2025
Low
Report
Lipocine Announces Financial Results for the Full Year Ended December 31, 2025
2/18
08:00 am
lpcn
Lipocine Announces Last Patient Last Visit in Pivotal Phase 3 Trial of LPCN 1154 for Postpartum Depression (PPD)
Low
Report
Lipocine Announces Last Patient Last Visit in Pivotal Phase 3 Trial of LPCN 1154 for Postpartum Depression (PPD)
2/15
01:09 am
lpcn
Medium
Report
2/11
03:28 pm
lpcn
Buy Rating Maintained on Lipocine Inc. (LPCN) as Target Climbs to $15 [Yahoo! Finance]
Low
Report
Buy Rating Maintained on Lipocine Inc. (LPCN) as Target Climbs to $15 [Yahoo! Finance]